DTC Healthcare with 23andMe CEO Anne Wojcicki
Genes aren’t always predictive, but understanding them better could dramatically improve our healthcare system. Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe, about her company and why it’s looking to tell you much more than the names of your long-lost relatives. They discuss: -…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Motley Fool Hidden Gems Investing
See all episodes →Dick’s Sporting Goods has a Foot Locker Problem
1 Earnings Report That Could Move the Market
America Is 10x Behind China in AI Infrastructure — The CEO Building the Solution
Similar episodes from other shows
More like Motley Fool Hidden Gems Investing →
Healthcare is Broken—This Company Wants to Fix It
Understanding The Big Tech Stocks
Andreessen Horowitz's Vijay Pande: "AI doctors"
Longevity: Can We Add Another 30 Years? | The Decade Ahead
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.